Unlocking the Potential of Biosimilars in Immuno-Oncology

NPC1: A Potential Target For Triple-Negative Breast Cancer

Hypoxia-Dependent CAR Stabilizing Construct in T cells Improves Solid Tumor Targeting and Efficacy

Harnessing Natural Killer Cell Activity for Anti-Tumor Immunotherapy

Targeting Success in CAR-T Therapy for Solid Tumors

CAR-T poster

By Jacqueline Carrico, BS, MD Candidate